The statement goes that within the tribes of the Navajo Indians, the Hunzas the Abkhasians and many others, there has never been any cases of cancer
Well, that's certainly one of the more interesting (if completely fallacious) statements so far!
Here's the problem:
The believers accuse Big Pharma, etc etc, of hiding cures; masking results; faking studies and the like.
The detractors accuse the believers of conducting shoddy research; of preying on the sick and dying; of blatant fraudhood.
So who to believe?
Let's consider that B-17 is not a newly discovered substance; in fact since the 1970s it's been studied quite extensively.
No one has found it to be more efficacious than radiation or chemo from the articles that I've read - however are we to believe that every study
since 1971 has been part of a growing conspiracy to keep B-17 off of the shelves?
If that's the case, are we then to believe that this conspiracy reaches every pharmaceutical community around the world? "Big Pharma" isn't one
company, or one nation; indeed many countries have regulations in place which actually cap the public cost of certain drugs, thereby controlling (to
an extent) the profit margin available. There are also hundreds of pharmaceutical companies, spread around the world - a conspiracy of this nature
would have to involve most, if not all, at some level.
Is that likely? I really don't think so.
What I think is more likely
is that if B-17 is effective at all (which is dubious at best), then it would probably be a great treatment to use
in conjunction with other therapies; unless someone can show me cases of proven B-17 cures? Sorry, I have tried searching, but I keep hitting
anecdotal evidence and nothing concrete.
List of study sources:
Gostomski FE: The effects of amygdalin on the Krebs-2 carcinoma and adult and fetal DUB(ICR) mice. [Abstract] Diss Abstr Int B 39 (5): 2075-B,
Wodinsky I, Swiniarski JK: Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of
transplantable rodent tumors. Cancer Chemother Rep 59 (5): 939-50, 1975 Sep-Oct. [PUBMED Abstract]
Laster WR Jr, Schabel FM Jr: Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase
(NSC-128056). Cancer Chemother Rep 59 (5): 951-65, 1975 Sep-Oct. [PUBMED Abstract]
Stock CC, Tarnowski GS, Schmid FA, et al.: Antitumor tests of amygdalin in transplantable animal tumor systems. J Surg Oncol 10 (2): 81-8, 1978.
Newton GW, Schmidt ES, Lewis JP, et al.: Amygdalin toxicity studies in rats predict chronic cyanide poisoning in humans. West J Med 134 (2): 97-103,
1981. [PUBMED Abstract]
Hill GJ 2nd, Shine TE, Hill HZ, et al.: Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia. Cancer Res 36 (6): 2102-7, 1976. [PUBMED
Lea MA, Koch MR: Effects of cyanate, thiocyanate, and amygdalin on metabolite uptake in normal and neoplastic tissues of the rat. J Natl Cancer Inst
63 (5): 1279-83, 1979. [PUBMED Abstract]
Carter JH, McLafferty MA, Goldman P: Role of the gastrointestinal microflora in amygdalin (laetrile)-induced cyanide toxicity. Biochem Pharmacol 29
(3): 301-4, 1980. [PUBMED Abstract]
Khandekar JD, Edelman H: Studies of amygdalin (laetrile) toxicity in rodents. JAMA 242 (2): 169-71, 1979. [PUBMED Abstract]
Ovejera AA, Houchens DP, Barker AD, et al.: Inactivity of DL-amygdalin against human breast and colon tumor xenografts in athymic (nude) mice. Cancer
Treat Rep 62 (4): 576-8, 1978. [PUBMED Abstract]